CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 3,493 shares at an average $14.03 ($49,011)
- 4 Planned sale CEO and Chairman sold 3,600 shares at an average $14.09 ($50,706)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 107 shares at $13.99 ($1,497)
- 144 Insider Sale of Securities
- 4 Planned sale CEO and Chairman sold 500 shares at $14.13 ($7,065)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 1,800 shares at an average $13.99 ($25,183)
- 4 Planned sale CEO and Chairman sold 1,300 shares at $14.01 ($18,213)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 12,400 shares at an average $14.05 ($174,175)
Page 5 of 14 · 277 filings